The effect of vitamin D supplementation on plasma high sensitivity C-reactive protein and P-selectin in patients with thromboembolism
Phase 2
- Conditions
- Thrombosis.Venous embolism and thrombosis
- Registration Number
- IRCT201407048307N7
- Lead Sponsor
- Vice Chancellor for Research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with confirmed acute thrombosis; vitamin D deficiency; patients with 18 years old and over; consented patients.
Exclusion criteria: Hypercalcemia; nephrolithiasis; Sarcoidosis; vitamin D supplementation; malabsorbtion syndrome; Severe infection; uncontrolled autoimmune and inflammatory diseases; pregnancy; drugs and conditions that affect the P-selectin and high sensitivity C-reactive protein levels.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of high sensitivity C-reactive protein. Timepoint: Before, 1 month and 3 months after intervention. Method of measurement: ELISA.;Level of P-selectin. Timepoint: Before,1 month and 3 months after intervention. Method of measurement: ELISA.;Level of 25-hydroxy vitamin D. Timepoint: Before, 1 and 3 months after intervention. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method